Relative resistance to apoptosis and the ability to proliferate and produce a collagen-rich scar determine the critical role of cardiac fibroblasts in wound healing and tissue remodeling following myocardial injury. Identification of cardiac fibroblast-specific factors and mechanisms underlying these aspects of cardiac fibroblast function is therefore of considerable scientific and clinical interest. In the present study, gene knockdown and overexpression approaches, and promoter binding assays, showed that DDR2, a mesenchymal cell-specific collagen receptor tyrosine kinase localized predominantly in fibroblasts in the heart, acts via ERK1/2 MAPK-activated SRF transcription factor to enhance the expression of anti-apoptotic cIAP2 in cardiac fibroblasts, conferring resistance against oxidative injury.
Results:
DDR2 mediates Ang II-stimulated expression of anti-apoptotic cIAP2 in cardiac fibroblasts
The intra-cardiac generation of Ang II is enhanced following myocardial injury, which exposes the different cell types in the heart to its pleiotropic actions (20) .
Paradoxically, while Ang II is reported to induce apoptosis in cardiac myocytes (21, 22) , it promotes cardiac fibroblast activation post injury and is a potent profibrotic factor with marked stimulatory effect on collagen expression in cardiac fibroblasts (20) . These observations prompted us to explore the possible prosurvival role of Ang II in cardiac fibroblasts and delineate the underlying mechanisms, focusing specifically on the role of DDR2.
First, we examined the effect of Ang II on the expression of cellular Inhibitor of Apoptosis, cIAP2, which was earlier shown by us to play a key role in cardiac fibroblast resistance to oxidative stress (9).
Ang II induced a 3-fold increase in cIAP2 mRNA at 6 h ( Figure 1A) and a 2-fold increase in cIAP2 protein expression at 12 h post-treatment ( Figure 1B) , determined by RT-qPCR and western blotting, respectively.
Notably, DDR2 knockdown in cardiac fibroblasts using specific siRNA prevented Ang II-stimulated cIAP2 expression ( Figure 1C) , showing that DDR2 mediates the stimulatory effect of Ang II on cIAP2 expression. Further, DDR2 overexpression in un-stimulated cells enhanced cIAP2 expression ( Figure 1D ), clearly demonstrating its role in cIAP2 regulation.
DDR2-dependent ERK1/2 MAPK activation acts via Serum Response Factor to transcriptionally up-regulate cIAP2 expression in Ang II-stimulated cardiac fibroblasts
Since bioinformatic analysis of cIAP2 promoter region revealed binding sites for Serum Response Factor (SRF), we probed its possible involvement in the regulation of Ang II-dependent cIAP2 expression.
SRF knockdown with specific siRNA was found to abolish cIAP2 in Ang IIstimulated cells, indicating its role in cIAP2 expression ( Figure  2A ).
Importantly, while SRF knockdown did not affect DDR2 expression (Figure 2A ), knockdown of DDR2 down-regulated SRF levels ( Figure 2C ), confirming that DDR2 regulates cIAP2 via SRF in Ang IIstimulated cells. Further, chromatin immunoprecipitation assay (ChIP) demonstrated SRF binding to the promoter region of cIAP2 in Ang II-treated cells, which was attenuated in DDR2-silenced cells ( Figure 2B ).
As previously reported by us, we observed DDR2-dependent activation of ERK1/2 MAPK in Ang II-stimulated cells ( Figure   2D ). Further, ERK1/2 MAPK knockdown down-regulated Ang II-stimulated SRF expression and cIAP2 expression ( Figure   2E and Figure 2F) , showing that DDR2 increases cIAP2 levels via ERK1/2 MAPK and SRF in Ang II-stimulated cells.
DDR2-dependent cIAP2 expression protects cardiac fibroblasts against oxidative damage
We had reported earlier that cIAP2, induced in response to H 2 O 2 , protects cardiac fibroblasts against oxidative damage (9). Additionally, we had also shown that H 2 O 2 treatment promotes Ang II production in cardiac fibroblasts (23).
Pursuing these observations, we found that blocking the Ang II receptor, AT1, with candesartan attenuated cIAP2 expression ( Figure 3A.) showed that DDR2 knockdown in mitogen-stimulated cells results in cell cycle arrest at the G1 phase ( Figure 4A ).
Further, western blot analysis showed that DDR2 knockdown in mitogen-stimulated cells results in a significant reduction in the levels of Proliferating Cell Nuclear Antigen (PCNA), an S-phase marker ( Figure 4B ). Skp2 is an E3 ubiquitin ligase that targets various inhibitors of G1-S transition, which includes p27 belonging to the CIP/KIP family of cyclin-dependent kinase (CDK) inhibitors (24). We found that DDR2 knockdown attenuates Skp2 levels ( Figure 4B ), resulting in p27 induction ( Figure  4B ) and Rb hypophosphorylation ( Figure  4C ), culminating in G1 arrest of mitogenstimulated cells. Consistent with G1 phase arrest, cyclin E, an S-Phase cyclin, but not Cyclin D1, a G1-phase cyclin, was significantly reduced in DDR2-silenced, mitogen-stimulated cells ( Figure 4D ).
Together, these data suggest that DDR2
has an obligate role in G1-S transition via positive regulation of Skp2 and negative regulation of p27.
Regulation of Skp2 by DDR2-dependent SRF
Based on bioinformatics analysis, the possible involvement of SRF in DDR2dependent Skp2 expression was probed next. SRF knockdown was found to downregulate Skp2 ( Figure 5A ), showing that SRF is involved in the regulation of Skp2.
Following this, it was of obvious interest to examine the link between DDR2 and SRF. DDR2 knockdown in serumstimulated cells led to down-regulation of SRF ( Figure 5B ). Moreover, ERK1/2 MAPK knockdown in mitogen-stimulated cells reduced SRF levels ( Figure 5C ).
Since DDR2 promotes ERK1/2 activation ( Figure 5D ), these data point to DDR2- ChIP assay ( Figure 5E ).
Regulation of p27 by DDR2 i) Post-translational regulation via SRFdependent Skp2
Since Skp2 is known to posttranslationally degrade p27 (24) in mitogen-stimulated cells ( Figure 5F) and cause cell cycle arrest at the G1 phase ( Figure 5G ), suggesting that SRF may transcriptionally regulate Skp2 expression to degrade p27 and promote G1-S transition.
ii) Transcriptional regulation through modulating FoxO3a activity
Since p27 was found to be up-regulated in DDR2-silenced, mitogen-stimulated cells ( Figure 4B ), we probed its transcriptional regulation by FoxO3a transcription factor whose phosphorylation leads to its inactivation and sequestration in the cytoplasm while its non-phosphorylated form translocates to the nucleus and transcribes the p27 gene to result in G1 arrest (10, (25) (26) (27) (28) . We found that DDR2 knockdown in mitogen-stimulated cells reduces FoxO3a phosphorylation, leading to its activation ( Figure 6A ), which corresponded with enhanced p27 and reduced PCNA levels ( Figure 4B ).
Consistent with these observations, chromatin immunoprecipitation showed enhanced binding of FoxO3a to the p27 gene promoter in DDR2-silenced, mitogen-stimulated cells ( Figure 6B ).
Subsequently, we also examined the mechanism by which DDR2 regulates Figure 7D ), a significant increase in SRF levels ( Figure 7E ) and elevated Phospho-FoxO3a (inactivation) levels ( Figure 7E ).
As expected, siRNA-mediated ERK1/2 MAPK inhibition in DDR2-overexpressing cells attenuated PCNA expression ( Figure   7F ), showing that ERK1/2 MAPK mediates the DDR2 effects. and PCNA ( Figure 7G ). Further, while serum from both SHR and control rats enhanced the levels of DDR2, SRF, cIAP2
Enhanced expression of DDR2
and PCNA in cardiac fibroblasts in vitro, serum from SHR had more pronounced effects ( Figure 7H ), which were reduced upon pre-treatment of the cells with candesartan.
A schematic representation of the plausible molecular events that integrate apoptosis resistance and proliferation under the regulatory control of DDR2 in cardiac fibroblasts is provided in Supplementary Figure S1A. 
Discussion

Materials and Experimental procedure:
Materials
Angiotensin II, CCG-1423, Candesartan cilexetil and M199 were obtained from Sigma- 
Experimental procedures:
Isolation of cardiac fibroblasts
Cardiac fibroblasts were isolated from young adult male Sprague-Dawley rats (2-3 months old) as described earlier (59 Cardiac fibroblasts were also isolated from 6 month-old male Wistar and Spontaneously
Hypertensive Rats (SHR) as described earlier (59). Cells were collected after a brief wash 2.5 h post initial plating to obtain cardiac fibroblasts. These cells were collected and processed further to analyse the expression of various genes and proteins.
Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) analysis
Subconfluent cultures of cardiac fibroblasts were subjected to the indicated treatments and total RNA was isolated using the PureLink RNA isolation kit (Invitrogen), according to the manufacturer's instructions. Following DNase I treatment, 2μg of total RNA was reverse transcribed to cDNA with random primers and M-MLV reverse transcriptase. TaqMan RT-qPCR analysis was carried out using the ABI prism 7500 Sequence Detection System (Applied Biosystems, CA, USA) with specific FAM-labeled probes for cIAP2(Birc2) (Assay ID: Rn00572734_m1), and VIC-labeled probes for β -actin (Rn00667869_m1). PCR reactions were performed under the following thermal cycling conditions: 95°C for 10 min followed by 40 cycles of denaturation at 95°C for 15 s and annealing/extension at 60°C for 1 min. Gene expression was quantified using C T values. mRNA expression was normalized to that of β actin. The relative fold-change in target mRNA levels of treated versus control was quantified using the 2 -∆∆Ct method.
Western blot analysis
Subconfluent cultures of cardiac fibroblasts in serum-free M199 were treated with Ang II (1μM), or 10% Fetal Calf Serum (mitogen) and relative protein abundance was determined by western blot analysis following standard protocols, with β -actin as loading control.
Enhanced chemiluminescence reagent was used to detect the proteins with X-ray Film.
RNA interference and overexpression
Cardiac fibroblasts at passage 3 were seeded on 60mm dishes at equal density. After 24 h, the cells were incubated in Opti-MEM for 5-6 h with Ambion pre-designed Silencer-Select siRNA, custom-designed siRNA from Eurogentech or scrambled siRNA (control siRNA) at the given concentrations (10nM for DDR2, 20nM for SRF and ERK1/2 MAPK) and
Lipofectamine 2000 (8μl).
Constitutive expression of DDR2 was achieved under the control of a CMV promoter. The 
Chromatin Immunoprecipitation (ChIP) assay
The ChIP assay was performed with the Low Cell Number ChIP kit, according to the manufacturer's protocol. Briefly, after treatment of cardiac fibroblasts with 1μM Ang II or 10% FCS for 30 min, the cells were cross-linked with 1% formaldehyde, lysed and sonicated in a Diagenode Bioruptor to generate ~600 bp DNA fragments. The lysates were incubated with anti-SRF or anti-FoxO3a antibody overnight at 4°C with rotation. Immune complexes were precipitated with protein A-coated magnetic beads. After digestion with proteinase K to remove the DNA-protein cross-links from the immune complexes, the DNA was isolated and 
Effect of serum from SHR on normal cardiac fibroblasts
Preparation of serum: Blood was collected from the descending aorta of anesthetized rats, and serum was separated by centrifugation. For experiments with cardiac fibroblasts, serum was filtered through 0.22µm membrane and used fresh. Cardiac fibroblasts from Wistar rats were exposed to serum from Wistar rats and SHR to achieve a final serum concentration of 10% in Medium M199.
Flow cytometry
Annexin V-PI staining
Cells were trypsinized, washed twice with cold PBS and re-suspended in 1X Binding Buffer at a concentration of 1 x 10 6 cells/ml. 5 µl of FITC Annexin V and 5 µl PI were added to 1 x 10 5 cells/100ul in a 5 ml culture tube, gently vortexed and incubated for 15 min at RT (25°C) in the dark. Cells were analyzed by flow cytometry after adding 400 µl of 1X Binding Buffer to each tube. Unstained cells, cells stained with only FITC Annexin V and cells stained with only PI were used as controls to set up compensation and quadrants. Flow cytometry was perfomed using BD FACSJazz™ Cell Sorter.
Cell cycle analysis
Cells were trypsinized, washed twice with cold PBS, re-suspended in 500ul PBS, fixed with an equal volume of 70% ethanol and stored at 4 0 C overnight. The cells were pelleted, washed twice in 1xPBS, re-suspended in 500ul 1xPBS and incubated at room temperature for 30 minutes with 50ug of RNase A. Following incubation with 200ul of Propidium Iodide in the dark for 15 min, the cells were analyzed by flow cytometry on BD FACSJazz™ Cell Sorter.
Statistical analysis
Data are expressed as Mean±SE. Statistical analysis was performed using Student's t test (unpaired, 2-tail) for comparisons involving 2 groups. For comparisons involving more than 2 groups, the data were analyzed by one-way ANOVA. p<0.05 was considered significant. The in vitro data presented are representative of 3 independent experiments (n=3). 3 age-matched (6 months) male SHR and Wistar rats were used in the in vivo experiments (n=3).
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